2009
DOI: 10.1111/j.1468-2982.2009.02000.x
|View full text |Cite
|
Sign up to set email alerts
|

‘Dual’ occipital and supraorbital nerve stimulation for primary headache

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 21 publications
(25 reference statements)
0
5
0
Order By: Relevance
“…but patient selection and follow-up biases may have influenced the results (46). The combined stimulation was found to be useful in a case series of four drugresistant sporadic hemiplegic migraine patients (47).…”
Section: Migrainementioning
confidence: 96%
See 1 more Smart Citation
“…but patient selection and follow-up biases may have influenced the results (46). The combined stimulation was found to be useful in a case series of four drugresistant sporadic hemiplegic migraine patients (47).…”
Section: Migrainementioning
confidence: 96%
“…This impressive result needs to be confirmed in a RCT. Combined ONS–SNS was found to be superior to ONS alone in a small retrospective study of chronic migraineurs (44), but patient selection and follow-up biases may have influenced the results (46). The combined stimulation was found to be useful in a case series of four drug-resistant sporadic hemiplegic migraine patients (47).…”
Section: Invasive Peripheral Nerve Neurostimulationmentioning
confidence: 99%
“…Following this flurry of brief mentions, anecdotal reports and preliminary experiences, several larger series and detailed technical reports were published further establishing the practice of PNS with percutaneous electrodes [57][58][59][60][61][62][63][64][65]. Use of PNS for migraines, suggested by Popeney and Aló [57] based on experience with 25 patients in an uncontrolled study, was supported by subsequent clinical publications [66][67][68][69] and in-depth imaging study [70]. Subsequent to that, three neuromodulation device manufacturing companies (Medtronic, St. Jude Medical and Boston Scientific) launched prospective randomized studies to determine benefits of occipital PNS for migraine patients; the high prevalence of migraines in general population and large number of medically intractable cases make this indication potentially largest in PNS applications.…”
Section: Pns Progress: Early Yearsmentioning
confidence: 96%
“…Subsequent to that, three neuromodulation device manufacturing companies (Medtronic, St. Jude Medical and Boston Scientific) launched prospective randomized studies to determine benefits of occipital PNS for migraine patients; the high prevalence of migraines in general population and large number of medically intractable cases make this indication potentially largest in PNS applications. In addition to occipital PNS with percutaneous electrodes, occipital PNS paddles [46] and a combination of supraorbital and occipital PNS [68,69] have been tried for migraine treatment and prevention.…”
Section: Pns Progress: Early Yearsmentioning
confidence: 99%
See 1 more Smart Citation